Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02920775
NCT02920775
Unknown
Not Applicable

Monitoring Patterns of Prescribing to Identify Changes in Access to ER/LA Opioid Analgesics

ER/LA Opioid REMS Program Companies (RPC)0 sites360,000 target enrollmentSeptember 30, 2016
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOpioid Related DisordersOpiate AddictionNarcotic AbuseDrug Abuse

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid Related Disorders
Sponsor
ER/LA Opioid REMS Program Companies (RPC)
Enrollment
360000
Primary Endpoint
Monthly volume of prescriptions by specialty
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Changes in prescribing will be compared in prescribers from specialties whose prescribing is hypothesized to be relatively unaffected by the REMS (such as oncologists and hospice providers) versus those for whom the REMS could have greater impact on prescribing (e.g., dentists). Trends and changes in monthly prescription volume and average monthly prescription volume will be evaluated by prescriber specialty.

Registry
clinicaltrials.gov
Start Date
September 30, 2016
End Date
July 2019
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ER/LA Opioid REMS Program Companies (RPC)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Changes in number of prescriptions for prescriber types with less or more compelling reasons to prescriber ER/LA opioid analgesics

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Monthly volume of prescriptions by specialty

Time Frame: July 2010-December 2014

Similar Trials

Completed
Not Applicable
Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.Perennial Allergic RhinitisAsthma
NCT04654702Hanmi Pharmaceutical Company Limited2,671
Recruiting
Not Applicable
The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR TabDiabetes Mellitus, Type 2
NCT06188234Hanlim Pharm. Co., Ltd.3,000
Unknown
Not Applicable
Evaluation of Changes in Prescribing Behavior of ER/LA Opioid PrescribersOpioid Related DisordersOpiate AddictionNarcotic AbuseDrug Abuse
NCT02920762ER/LA Opioid REMS Program Companies (RPC)5,575,834
Completed
Not Applicable
Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart DiseaseAtrial Fibrillation
NCT06239402Istituti Clinici Scientifici Maugeri SpA394
Completed
Not Applicable
A study to observe the drugs used in women with heavy menstrual bleedingHealth Condition 1: null- Dysfunctional uterine bleeding
CTRI/2018/05/013791Kempegowda institute of medical sciences and research hospital110